These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23320981)

  • 41. Chemotherapy extravasation from implanted ports.
    Schulmeister L; Camp-Sorrell D
    Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case of mitoxantrone extravasation.
    Chang A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1270-1273. PubMed ID: 31902285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Extravasation of cytostatic drugs].
    Pikó B; Puskásné Szatmári K; Bassam A; Csiffári M; Dimák S; Szabó Z; Ocsai H; Csotye J
    Magy Onkol; 2011 Mar; 55(1):4-13. PubMed ID: 21617786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Introduction of a clinical protocol for extravasation at the National Institute of Oncology, Budapest, Hungary].
    Bartal A; Mátrai Z; Rosta A; Szûcs A
    Magy Onkol; 2011 Mar; 55(1):14-20. PubMed ID: 21617787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.
    Curtit E; Chaigneau L; Pauchot J; Nguyen T; Nerich V; Bazan F; Thiery-Vuillemin A; Demarchi M; Pivot X; Villanueva C
    Anticancer Res; 2012 Apr; 32(4):1481-3. PubMed ID: 22493389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extravasation management: clinical update.
    Schulmeister L
    Semin Oncol Nurs; 2011 Feb; 27(1):82-90. PubMed ID: 21255716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe necrosis due to paclitaxel extravasation.
    Herrington JD; Figueroa JA
    Pharmacotherapy; 1997; 17(1):163-5. PubMed ID: 9017777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):573-6. PubMed ID: 22143379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical treatment of extravasation injuries.
    Napoli P; Corradino B; Badalamenti G; Tripoli M; Vieni S; Furfaro MF; Cordova A; Moschella F
    J Surg Oncol; 2005 Sep; 91(4):264-8; discussion 268-9. PubMed ID: 16121344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extravasation of chemotherapeutic agents: prevention and treatment.
    Goolsby TV; Lombardo FA
    Semin Oncol; 2006 Feb; 33(1):139-43. PubMed ID: 16473651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of accidental extravasation of antitumor agents with dimethylsulfoxide and alpha-tocopherol].
    Bonnetblanc JM; Bordessoule D; Fayol J; Amici JM
    Ann Dermatol Venereol; 1996; 123(10):640-3. PubMed ID: 9615123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.
    Pluschnig U; Haslik W; Bayer G; Soleiman A; Bartsch R; Lamm W; Steger GG; Zielinski CC; Mader RM
    Support Care Cancer; 2015 Jun; 23(6):1741-8. PubMed ID: 25433440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of liposuction and saline washout for the treatment of extensive subcutaneous extravasation of corrosive drugs.
    Martin PH; Carver N; Petros AJ
    Br J Anaesth; 1994 Jun; 72(6):702-4. PubMed ID: 8024922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Emergency open surgical treatment of extravasations of cytostatic agents in the upper extremity].
    Telisselis P; Heers G; Plock B; Baier C; Neugebauer R; Füchtmeier B
    Handchir Mikrochir Plast Chir; 2010 Aug; 42(4):247-50. PubMed ID: 19890780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GEDEFO-SEFH management of antineoplastic extravasations survey results.
    Jiménez-Pulido I; Albert-Marí MA; Conde-Estévez D; San José-Ruiz B; Gil-Lemus MÁ; Cercós-LLetí AC; Esteban-Mensua MJ; Díaz-Carrasco MS
    J Oncol Pharm Pract; 2024 Jan; 30(1):67-77. PubMed ID: 37032471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
    Tsavaris NB; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
    Cancer Chemother Pharmacol; 1992; 30(4):330-3. PubMed ID: 1643703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of Dexrazoxane for Extravasation of Anthracycline Antitumor Antibiotics - Reporting Measures Developed against Extravasation in the Hospital].
    Kawamoto S; Shirahata T; Katori T; Izumo T; Kadono H; Fujita H; Okamoto R
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2517-2521. PubMed ID: 28028257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Extravasation of cytostatic agents--what is a good treatment?].
    Dahl BH; Rindal R
    Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1830-3. PubMed ID: 7638831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.